MICHAEL MOELLER: Open Payments
NPI 1598765877 · MANKATO, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 9 payments from 7 companies in 2025. Trend: 2023 $50 · 2024 $118 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Alkermes, Inc. | 2 | $30 |
| Lundbeck LLC | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: COBENFY, REXULTI, ARISTADA, FANAPT, Auvelity, CAPLYTA.
Industry payments across MN — which companies pay providers there.
